Ibuprofen Tablets — Class II drug recall D-0647-2024
Ongoing recall by Preferred Pharmaceuticals, Inc., reported 2024-09-04, distributed in CA, NV. Failed Impurities/Degradation Specifications - at 18-month Stability testing
| Recall number | D-0647-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2024-08-08 |
| Classified | 2024-08-26 |
| Reported by FDA | 2024-09-04 |
| Distributed | CA, NV |
| Quantity | 266 bottles |
| Reason classes | specification failure |
| NDC | 68788-9110-03 |
| Lot numbers | B0223H, C3023H |
| Expiration dates | 2026-05-31, 2026-09-30 |
Product
Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
Reason for recall
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0647-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.